107 / 119
106
Diretrizes AMB
psoriasis. Br J Dermatol. 2008 Mar;158(3):549-57. Epub 2007 Nov 28.
PubMed PMID: 18047521.
21. Menter A, Gordon KB, Leonardi CL, Gu Y, Goldblum OM. Efficacy and
safety of adalimumab across subgroups of patients with moderate to
severe psoriasis. J Am Acad Dermatol. 2010 Sep;63(3):448-56. doi:
10.1016/j.jaad.2009.09.040. Epub 2010 Jun 3. PubMed PMID: 20605254.
22. Menter A, Tyring SK, Gordon K, Kimball AB, Leonardi CL, Langley RG,
Strober BE, Kaul M, Gu Y, Okun M, Papp K. Adalimumab therapy for
moderate to severe psoriasis: A randomized, controlled phase III trial. J